UTHSC’s Jonathan Wall Receives $1.79 Million To Develop New Amyloidosis Treatment
|The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.” Amyloidosis is a rare disease that occurs when abnormal protein… Read More